Literature DB >> 8124000

Immunological features of Down's syndrome: a review.

L Nespoli1, G R Burgio, A G Ugazio, R Maccario.   

Abstract

Young patients with Down's syndrome (DS) have high rates of infections, malignancies and autoimmune phenomena. Therefore, DS may be considered as a model of precocious, abnormal ageing of the thymus-dependent system in man. In DS children less than 6 years of age, the levels of serum immunoglobulins did not differ from healthy controls, but after that age, considerable hyper-IgG and -IgA were found. Furthermore, high levels of IgG1 and IgG3 have been found, whereas a progressive decline of IgG2 and IgG4 with age has been observed. The frequency of hepatitis B virus carriers even in the youngest age group is much higher among DS children. It has been reported that an IgG response was detectable in 75% of controls after HBsAg vaccination as compared to the 16.6% of DS patients. The presence of autoantibodies against human thyroglobulin did show a positive association with HB Virus Ag carriers, but only in the oldest DS subjects. Natural antibodies against intestinal antigens are low, while in the presence of cow's milk, abnormally high titres against casein and beta-lactoglobulin were present. High levels of IgG antibodies against gliadin have been observed. In spite of a normal percentage of CD3- and CD2-positive lymphocytes, a high proportion of cells express low-avidity receptors for sheep erythrocytes. Although the proportion of CD4+ T-lymphocyte helper-cells is normal, a marked imbalance in the CD4+ subpopulations has been documented. The percentage of suppressor-cytotoxic CD8+ lymphocytes is markedly increased. The responses to phytohemagglutinin and concanavalin A are within the normal range in the first decade of life and decline progressively thereafter. A recent study reported defective proliferative response to allo-mixed lymphocyte culture, with decreased expression of the membrane CD25, low secretion of interleukin 2 in the supernatant and depressed allo-specific cytotoxic activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8124000     DOI: 10.1111/j.1365-2788.1993.tb00324.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  17 in total

1.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

2.  Down's syndrome is strongly associated with coeliac disease.

Authors:  L Gale; H Wimalaratna; A Brotodiharjo; J M Duggan
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 3.  Aspects of digestive tract tumors in Down syndrome: a literature review.

Authors:  Daniel Satgé; Annie J Sasco; Michel J J Vekemans; Marie-Laure Portal; Jean-François Fléjou
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

4.  Down's syndrome and esophageal achalasia: a rare but important clinical entity.

Authors:  Manabu Okawada; Tadaharu Okazaki; Atsuyuki Yamataka; Geoffrey J Lane; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2005-12       Impact factor: 1.827

5.  Adults with Trisomy 21 Have Differential Antibody Responses to Influenza A.

Authors:  Stephanie James; Robert C Haight; Cassandra Hanna; Lindsey Furton
Journal:  Vaccines (Basel)       Date:  2022-07-19

6.  Plasma amino acids and neopterin in healthy persons with Down's syndrome.

Authors:  A W Coppus; D Fekkes; W M A Verhoeven; S Tuinier; J I M Egger; C M van Duijn
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

7.  Altered DNA methylation in leukocytes with trisomy 21.

Authors:  Kristi Kerkel; Nicole Schupf; Kota Hatta; Deborah Pang; Martha Salas; Alexander Kratz; Mark Minden; Vundavalli Murty; Warren B Zigman; Richard P Mayeux; Edmund C Jenkins; Ali Torkamani; Nicholas J Schork; Wayne Silverman; B Anne Croy; Benjamin Tycko
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

8.  Hospitalizations among people with Down syndrome: a nationwide population-based study in Denmark.

Authors:  Jin Liang Zhu; Henrik Hasle; Adolfo Correa; Diana Schendel; J M Friedman; Jørn Olsen; Sonja A Rasmussen
Journal:  Am J Med Genet A       Date:  2013-02-12       Impact factor: 2.802

Review 9.  Intrinsic defect of the immune system in children with Down syndrome: a review.

Authors:  M A A Kusters; R H J Verstegen; E F A Gemen; E de Vries
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

10.  Immune and TRG repertoire signature of the thymus in Down syndrome patients.

Authors:  Shira Rabinowicz; Atar Lev; Yu Nee Lee; Diti Machnes-Maayan; Uriel Katz; Amir Vardi; David Mishali; Raz Somech
Journal:  Pediatr Res       Date:  2020-03-31       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.